Glycaemic control, low levels of high-density lipoprotein, and high cardiovascular risk are associated with cardiovascular autonomic neuropathy
Abstract Background Cardiovascular autonomic neuropathy (CAN) is a life-threatening complication associated with diabetes but may also be present without diabetes. A glycaemic threshold for autonomic impairment is not yet established. The purpose of this study was to compare CAN status in people wit...
Saved in:
| Main Authors: | Tina Okdahl, Anne-Marie Wegeberg, Marie Møller Jensen, Jonas Salling Quist, Christina Brock |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Diabetology & Metabolic Syndrome |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13098-025-01834-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipoprotein(a) and cardiovascular disease: Evidence, recommendations and emerging therapies
by: Wong Nathan D.
Published: (2025-01-01) -
Lipoprotein(a), atherosclerosis and cardiovascular risk
by: E. A. Polyakova, et al.
Published: (2024-12-01) -
Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: insights from the Moli-sani cohort study
by: Francesco Gianfagna, et al.
Published: (2025-07-01) -
Predictors of lipoprotein(a) variability in clinical practice and their impact on cardiovascular risk
by: Hyung Joon Joo, et al.
Published: (2025-07-01) -
Lipoprotein(a) and Cardiovascular Disease in People Living With HIV: The Next Horizon
by: David B. Hanna, et al.
Published: (2024-12-01)